Related references
Note: Only part of the references are listed.DNA replication stress and cancer: cause or cure?
Elaine M. Taylor et al.
FUTURE ONCOLOGY (2016)
Disruption of the mevalonate pathway induces dNTP depletion and DNA damage
Covadonga Martin Sanchez et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2015)
The fork and the kinase: A DNA replication tale from a CHK1 perspective
Marina A. Gonzaelez Besteiro et al.
MUTATION RESEARCH-REVIEWS IN MUTATION RESEARCH (2015)
Exploiting replicative stress to treat cancer
Matthias Dobbelstein et al.
NATURE REVIEWS DRUG DISCOVERY (2015)
Loss of autophagy causes a synthetic lethal deficiency in DNA repair
Emma Y. Liu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Multiparametric Cell Cycle Analysis Using the Operetta High-Content Imager and Harmony Software with PhenoLOGIC
Andrew J. Massey
PLOS ONE (2015)
The checkpoint 1 kinase inhibitor LY2603618 induces cell cycle arrest, DNA damage response and autophagy in cancer cells
Feng-Ze Wang et al.
APOPTOSIS (2014)
γH2AX and Chk1 phosphorylation as predictive pharmacodynamic biomarkers of Chk1 inhibitor-chemotherapy combination treatments
Rebecca Rawlinson et al.
BMC CANCER (2014)
Chk1 Inhibition as a novel therapeutic strategy for treating triple-negative breast and ovarian cancers
Christopher Bryant et al.
BMC CANCER (2014)
Chk1 inhibition in p53-deficient cell lines drives rapid chromosome fragmentation followed by caspase-independent cell death
Christopher J. Del Nagro et al.
CELL CYCLE (2014)
Roles of Chk1 in cell biology and cancer therapy
Youwei Zhang et al.
INTERNATIONAL JOURNAL OF CANCER (2014)
Inhibition of the checkpoint kinase Chk1 induces DNA damage and cell death in human Leukemia and Lymphoma cells
Christopher Bryant et al.
MOLECULAR CANCER (2014)
MTH1 inhibition eradicates cancer by preventing sanitation of the dNTP pool
Helge Gad et al.
NATURE (2014)
CHEK again: Revisiting the development of CHK1 inhibitors for cancer therapy
S. McNeely et al.
PHARMACOLOGY & THERAPEUTICS (2014)
The pentose phosphate pathway and cancer
Krushna C. Patra et al.
TRENDS IN BIOCHEMICAL SCIENCES (2014)
VER-246608, a novel pan-isoform ATP competitive inhibitor of pyruvate dehydrogenase kinase, disrupts Warburg metabolism and induces context-dependent cytostasis in cancer cells
Jonathan D. Moore et al.
ONCOTARGET (2014)
Identification of Preferred Chemotherapeutics for Combining with a CHK1 Inhibitor
Yang Xiao et al.
MOLECULAR CANCER THERAPEUTICS (2013)
Quinoline 3-sulfonamides inhibit lactate dehydrogenase A and reverse aerobic glycolysis in cancer cells
Julia Billiard et al.
CANCER & METABOLISM (2013)
Targeting the S and G2 checkpoint to treat cancer
Tao Chen et al.
DRUG DISCOVERY TODAY (2012)
Recent developments in the use of γ-H2AX as a quantitative DNA double-strand break biomarker
Christophe E. Redon et al.
AGING-US (2011)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
被撤回的出版物: Selective killing of cancer cells by a small molecule targeting the stress response to ROS (Retracted article. See vol. 561, pg. 420, 2018)
Lakshmi Raj et al.
NATURE (2011)
Regulation of cancer cell metabolism
Rob A. Cairns et al.
NATURE REVIEWS CANCER (2011)
Targeting Chk1 in the replicative stress response
Yun Dai et al.
CELL CYCLE (2010)
Glutamine addiction: a new therapeutic target in cancer
David R. Wise et al.
TRENDS IN BIOCHEMICAL SCIENCES (2010)
Cancer cell metabolism: Warburg and beyond
Peggy P. Hsu et al.
CELL (2008)
Cleavage-mediated activation of Chk1 during apoptosis
Kenkyo Matsuura et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Specific role of Chk1 phosphorylations in cell survival and checkpoint activation
Hiroyuki Niida et al.
MOLECULAR AND CELLULAR BIOLOGY (2007)
The kinase LKB1 mediates glucose homeostasis in liver and therapeutic effects of metformin
RJ Shaw et al.
SCIENCE (2005)
Chk1 is essential for tumor cell viability following activation of the replication checkpoint
SH Cho et al.
CELL CYCLE (2005)
Differential mode of regulation of the checkpoint kinases CHK1 and CHK2 by their regulatory domains
CP Ng et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Share Paper
